TP53 and prostate carcinoma: On the other hand, the high expression of DLGAP5 in prostate cancer enhanced the destabilization of p53 and ATM proteins mediated by DLGAP5, thereby inhibiting gamma radiation-induced apoptosis (Hassan et al., 2016).